Pharmacological profile of dopaminergic transmission in HIV-1 inducible Tat transgenic mice

被引：0
|
作者：
Strauss, M. J. [1 ]
Denehy, E. D. [2 ]
Zhou, L. [1 ]
Sun, W. L. [1 ]
Quizon, P. M. [1 ]
Eans, S. O. [3 ]
Cirino, T. J. [3 ]
Bardo, M. T. [2 ]
McLaughlin, J. P. [3 ]
Zhu, J. [1 ]
机构：
[1] Univ South Carolina, Drug Discovery & Biomed Sci, Columbia, SC 29208 USA
[2] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA
[3] Univ Florida, Dept Pharmacodynam, Coll Pharm, Gainesville, FL 32611 USA
来源：
JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 2017年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W58
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
  • [41] Tat and the HIV-1 promoter
    Jones, Katherine A.
    CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (03) : 461 - 468
  • [42] SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice
    Zhu, Jun
    Quizon, Pamela M.
    Wang, Yingying
    Adeniran, Charles A.
    Strauss, Matthew J.
    Jimenez-Torres, Ana C.
    Patel, Palak
    Cirino, Thomas J.
    Eans, Shainnel O.
    Hammond, Haylee R.
    Deliscar, Laure S.
    O'Hara, Priscilla
    Saini, Surendra K.
    Ofori, Edward
    Vekariya, Rakesh H.
    Zhang, Sixue
    Moukha-Chafiq, Omar
    Nguyen, Theresa H.
    Ananthan, Subramaniam
    Augelli-Szafran, Corinne E.
    Zhan, Chang-Guo
    McLaughlin, Jay P.
    NEUROPHARMACOLOGY, 2022, 220
  • [43] HIV-1 TAT AS AN EXTRACELLULAR REGULATOR OF HIV-1 ACTIVITY
    WEINBERGER, O
    MARCUZZI, A
    DOBKIN, J
    THOMAS, CA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 5 - 5
  • [44] Dilated Cardiomyopathy in Transgenic Mice Expressing HIV Tat
    Qiujuan Fang
    Hong Kan
    William Lewis
    Fangping Chen
    Puneet Sharma
    Mitchell S. Finkel
    Cardiovascular Toxicology, 2009, 9 : 39 - 45
  • [45] Dilated Cardiomyopathy in Transgenic Mice Expressing HIV Tat
    Fang, Qiujuan
    Kan, Hong
    Lewis, William
    Chen, Fangping
    Sharma, Puneet
    Finkel, Mitchell S.
    CARDIOVASCULAR TOXICOLOGY, 2009, 9 (01) : 39 - 45
  • [46] Impact of HIV-1 tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 tat transgenic mice
    Zhu, Jun
    Cirincione, Abagail B.
    Strauss, Matthew J.
    Davis, Sarah E.
    Eans, Shainnel O.
    Tribbitt, Danielle K.
    Alshakhshir, Nadine
    McLaughlin, Jay P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 984
  • [47] An inducible Tat transgenic mouse model for the study of HIV Neurologic complications
    Galey, David
    Reid, Rollie
    Wheeler, David
    Haughey, Norman
    Chauhan, Ashok
    Nath, Avindra
    JOURNAL OF NEUROVIROLOGY, 2006, 12 : 28 - 29
  • [48] Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein br
    Toma, Wisam
    Paris, Jason J.
    Warncke, Urszula O.
    Nass, Sara R.
    Caillaud, Martial
    McKiver, Bryan
    Ondo, Olivia
    Bagdas, Deniz
    Bigbee, John
    Knapp, Pamela E.
    Hauser, Kurt F.
    Damaj, M. Imad
    EXPERIMENTAL NEUROLOGY, 2022, 358
  • [49] HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice
    McLane, Virginia D.
    Lark, Arianna R. S.
    Nass, Sara R.
    Knapp, Pamela E.
    Hauser, Kurt F.
    NEUROSCIENCE LETTERS, 2022, 782
  • [50] Effects of acute Δ9-tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
    Yadav-Samudrala, Barkha J.
    Gorman, Benjamin L.
    Dodson, Hailey
    Ramineni, Shreya
    Wallace, E. Diane
    Peace, Michelle R.
    Poklis, Justin L.
    Jiang, Wei
    Fitting, Sylvia
    BRAIN RESEARCH, 2024, 1822
12345